Datopotamab deruxtecan induces hallmarks of immunogenic cell death
Antibody-drug conjugates (ADCs) offer a strategy for targeted delivery of cytotoxic agents to cancer cells. In this study, we investigated the mechanism of action of datopotamab deruxtecan, an ADC composed of a monoclonal antibody targeting tumor-associated calcium signal transducer 2 (TACSTD2, also...
Saved in:
| Main Authors: | Sabrina Forveille, Marion Leduc, Allan Sauvat, Guido Kroemer, Oliver Kepp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shared Science Publishers OG
2025-08-01
|
| Series: | Cell Stress |
| Subjects: | |
| Online Access: | http://microbialcell.com/researcharticles/2025a-forveille-cell-stress |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patritumab deruxtecan induces immunogenic cell death
by: Sabrina Forveille, et al.
Published: (2025-12-01) -
Immunogenic cell death and bystander killing: expanding the therapeutic potential of modern antibody-drug conjugates
by: Oliver Kepp, et al.
Published: (2025-12-01) -
Cytoplasmic HMGB2 orchestrates CALR translocation in the course of immunogenic cell death
by: Peng Liu, et al.
Published: (2024-12-01) -
Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01) -
Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces
by: W. van der Wulp, et al.
Published: (2024-12-01)